

Seed Biotech®
In contrast to our Network Partners offering and service, Allogeneic Solutions, in concert with Seed Biotech®, offers aril® acellular allograft amniotic membrane. This option is ideal for experienced clinicians and practices who manage their IVR processes independently, emphasizing Seed Biotech's advanced technology and product quality.
Consistent with Seed Biotech's mission to prioritize clinical convenience, practicality, and effectiveness, numerous considerations were incorporated into the design of their product lines. From the packaging to the shape configurations, everything relates to optimizing suitability for use and potential for clinical benefit. But, FIRST AND FOREMOST, its products were developed with design requirements for safety, and products provided for distribution are verified to satisfy these requirements, ensuring the highest level of safety and quality.
What sets Seed Biotech apart is its process. They use precise methods to achieve measurable results and create better biologic products. Their proprietary decellularization process demonstrates a greater than 95% reduction in DNA.
Under the guidance of clinical and industry-experienced experts, Seed Biotech's core competency is based on a novel decellularization and stabilization process conducted in a quality by-design facility with advanced operational support systems. Seed Biotech's unique ability to optimally prepare highly variable biological materials through a dynamic purification process that depletes biomaterials of cells and cellular contents without imparting unintentional alterations to the extracellular matrix comprised of soluble and non-soluble bioactive constituents positions it as an industry leader in innovation and a manufacturer of high-quality products.
Our direct "drop ship" relationship with Seed Biotech ensures that clinicians receive products swiftly and efficiently, enhancing their capacity to deliver timely and effective patient care.
RingBack Request

